The Mathematical Institute, University of Oxford, Eprints Archive

Browse by Author

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Creators | Item Type | No Grouping
Number of items: 9.

Economopoulou, P

Kefala, M and Papageorgiou, S G and Kontos, C K and Economopoulou, P and Tsanas, A and Panayiotides, I G and Gorgoulis, V G and Patsouris, E and Foukas, P G (2013) Increased expression of phosphorrylated NBS1, a key molecule of the DNA damage response machinery, is an adverse prognostic factor in patients with de novo myelodysplastic syndromes. Leukemia Research, 37 (11). pp. 1576-1582.

Foukas, P

Kefala, M and Papageorgiou, S G and Kontos, C K and Economopoulou, P and Tsanas, A and Panayiotides, I G and Gorgoulis, V G and Patsouris, E and Foukas, P G (2013) Increased expression of phosphorrylated NBS1, a key molecule of the DNA damage response machinery, is an adverse prognostic factor in patients with de novo myelodysplastic syndromes. Leukemia Research, 37 (11). pp. 1576-1582.

Gorgoulis, V

Kefala, M and Papageorgiou, S G and Kontos, C K and Economopoulou, P and Tsanas, A and Panayiotides, I G and Gorgoulis, V G and Patsouris, E and Foukas, P G (2013) Increased expression of phosphorrylated NBS1, a key molecule of the DNA damage response machinery, is an adverse prognostic factor in patients with de novo myelodysplastic syndromes. Leukemia Research, 37 (11). pp. 1576-1582.

Kefala, M

Kefala, M and Papageorgiou, S G and Kontos, C K and Economopoulou, P and Tsanas, A and Panayiotides, I G and Gorgoulis, V G and Patsouris, E and Foukas, P G (2013) Increased expression of phosphorrylated NBS1, a key molecule of the DNA damage response machinery, is an adverse prognostic factor in patients with de novo myelodysplastic syndromes. Leukemia Research, 37 (11). pp. 1576-1582.

Kontos, C

Kefala, M and Papageorgiou, S G and Kontos, C K and Economopoulou, P and Tsanas, A and Panayiotides, I G and Gorgoulis, V G and Patsouris, E and Foukas, P G (2013) Increased expression of phosphorrylated NBS1, a key molecule of the DNA damage response machinery, is an adverse prognostic factor in patients with de novo myelodysplastic syndromes. Leukemia Research, 37 (11). pp. 1576-1582.

Panayiotides, I

Kefala, M and Papageorgiou, S G and Kontos, C K and Economopoulou, P and Tsanas, A and Panayiotides, I G and Gorgoulis, V G and Patsouris, E and Foukas, P G (2013) Increased expression of phosphorrylated NBS1, a key molecule of the DNA damage response machinery, is an adverse prognostic factor in patients with de novo myelodysplastic syndromes. Leukemia Research, 37 (11). pp. 1576-1582.

Papageorgiou, S

Kefala, M and Papageorgiou, S G and Kontos, C K and Economopoulou, P and Tsanas, A and Panayiotides, I G and Gorgoulis, V G and Patsouris, E and Foukas, P G (2013) Increased expression of phosphorrylated NBS1, a key molecule of the DNA damage response machinery, is an adverse prognostic factor in patients with de novo myelodysplastic syndromes. Leukemia Research, 37 (11). pp. 1576-1582.

Patsouris, E

Kefala, M and Papageorgiou, S G and Kontos, C K and Economopoulou, P and Tsanas, A and Panayiotides, I G and Gorgoulis, V G and Patsouris, E and Foukas, P G (2013) Increased expression of phosphorrylated NBS1, a key molecule of the DNA damage response machinery, is an adverse prognostic factor in patients with de novo myelodysplastic syndromes. Leukemia Research, 37 (11). pp. 1576-1582.

Tsanas, A

Kefala, M and Papageorgiou, S G and Kontos, C K and Economopoulou, P and Tsanas, A and Panayiotides, I G and Gorgoulis, V G and Patsouris, E and Foukas, P G (2013) Increased expression of phosphorrylated NBS1, a key molecule of the DNA damage response machinery, is an adverse prognostic factor in patients with de novo myelodysplastic syndromes. Leukemia Research, 37 (11). pp. 1576-1582.

This list was generated on Wed Aug 23 10:14:57 2017 BST.